249 related articles for article (PubMed ID: 36102038)
1. N-glycoproteomics reveals distinct glycosylation alterations in NGLY1-deficient patient-derived dermal fibroblasts.
Budhraja R; Saraswat M; De Graef D; Ranatunga W; Ramarajan MG; Mousa J; Kozicz T; Pandey A; Morava E
J Inherit Metab Dis; 2023 Jan; 46(1):76-91. PubMed ID: 36102038
[TBL] [Abstract][Full Text] [Related]
2. NGLY1 Deficiency, a Congenital Disorder of Deglycosylation: From Disease Gene Function to Pathophysiology.
Pandey A; Adams JM; Han SY; Jafar-Nejad H
Cells; 2022 Mar; 11(7):. PubMed ID: 35406718
[No Abstract] [Full Text] [Related]
3. Comparative proteomics reveals elevated CCN2 in NGLY1-deficient cells.
Hetz R; Magaway C; Everett J; Li L; Willard BB; Freeze HH; He P
Biochem Biophys Res Commun; 2022 Dec; 632():165-172. PubMed ID: 36209585
[TBL] [Abstract][Full Text] [Related]
4. Regulation of BMP4/Dpp retrotranslocation and signaling by deglycosylation.
Galeone A; Adams JM; Matsuda S; Presa MF; Pandey A; Han SY; Tachida Y; Hirayama H; Vaccari T; Suzuki T; Lutz CM; Affolter M; Zuberi A; Jafar-Nejad H
Elife; 2020 Jul; 9():. PubMed ID: 32720893
[TBL] [Abstract][Full Text] [Related]
5. N-Glycanase 1 Transcriptionally Regulates Aquaporins Independent of Its Enzymatic Activity.
Tambe MA; Ng BG; Freeze HH
Cell Rep; 2019 Dec; 29(13):4620-4631.e4. PubMed ID: 31875565
[TBL] [Abstract][Full Text] [Related]
6. Cytosolic N-GlcNAc proteins are formed by the action of endo-β-N-acetylglucosaminidase.
Maynard JC; Fujihira H; Dolgonos GE; Suzuki T; Burlingame AL
Biochem Biophys Res Commun; 2020 Oct; 530(4):719-724. PubMed ID: 32782141
[TBL] [Abstract][Full Text] [Related]
7. The cytoplasmic peptide:N-glycanase (NGLY1) - Structure, expression and cellular functions.
Suzuki T; Huang C; Fujihira H
Gene; 2016 Feb; 577(1):1-7. PubMed ID: 26611529
[TBL] [Abstract][Full Text] [Related]
8. A conserved role for AMP-activated protein kinase in NGLY1 deficiency.
Han SY; Pandey A; Moore T; Galeone A; Duraine L; Cowan TM; Jafar-Nejad H
PLoS Genet; 2020 Dec; 16(12):e1009258. PubMed ID: 33315951
[TBL] [Abstract][Full Text] [Related]
9. Liver-specific deletion of Ngly1 causes abnormal nuclear morphology and lipid metabolism under food stress.
Fujihira H; Masahara-Negishi Y; Akimoto Y; Hirayama H; Lee HC; Story BA; Mueller WF; Jakob P; Clauder-Münster S; Steinmetz LM; Radhakrishnan SK; Kawakami H; Kamada Y; Miyoshi E; Yokomizo T; Suzuki T
Biochim Biophys Acta Mol Basis Dis; 2020 Mar; 1866(3):165588. PubMed ID: 31733337
[TBL] [Abstract][Full Text] [Related]
10. Urine oligosaccharide screening by MALDI-TOF for the identification of NGLY1 deficiency.
Hall PL; Lam C; Alexander JJ; Asif G; Berry GT; Ferreira C; Freeze HH; Gahl WA; Nickander KK; Sharer JD; Watson CM; Wolfe L; Raymond KM
Mol Genet Metab; 2018 May; 124(1):82-86. PubMed ID: 29550355
[TBL] [Abstract][Full Text] [Related]
11. Aspartylglycosamine is a biomarker for NGLY1-CDDG, a congenital disorder of deglycosylation.
Haijes HA; de Sain-van der Velden MGM; Prinsen HCMT; Willems AP; van der Ham M; Gerrits J; Couse MH; Friedman JM; van Karnebeek CDM; Selby KA; van Hasselt PM; Verhoeven-Duif NM; Jans JJM
Mol Genet Metab; 2019 Aug; 127(4):368-372. PubMed ID: 31311714
[TBL] [Abstract][Full Text] [Related]
12. Ngly1 -/- rats develop neurodegenerative phenotypes and pathological abnormalities in their peripheral and central nervous systems.
Asahina M; Fujinawa R; Nakamura S; Yokoyama K; Tozawa R; Suzuki T
Hum Mol Genet; 2020 Jun; 29(10):1635-1647. PubMed ID: 32259258
[TBL] [Abstract][Full Text] [Related]
13. Ever-expanding NGLY1 biology.
Suzuki T; Yoshida Y
J Biochem; 2022 Feb; 171(2):141-143. PubMed ID: 34969094
[TBL] [Abstract][Full Text] [Related]
14. Prospective phenotyping of NGLY1-CDDG, the first congenital disorder of deglycosylation.
Lam C; Ferreira C; Krasnewich D; Toro C; Latham L; Zein WM; Lehky T; Brewer C; Baker EH; Thurm A; Farmer CA; Rosenzweig SD; Lyons JJ; Schreiber JM; Gropman A; Lingala S; Ghany MG; Solomon B; Macnamara E; Davids M; Stratakis CA; Kimonis V; Gahl WA; Wolfe L
Genet Med; 2017 Feb; 19(2):160-168. PubMed ID: 27388694
[TBL] [Abstract][Full Text] [Related]
15. Integrative glycoproteomics reveals protein N-glycosylation aberrations and glycoproteomic network alterations in Alzheimer's disease.
Zhang Q; Ma C; Chin LS; Li L
Sci Adv; 2020 Oct; 6(40):. PubMed ID: 33008897
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive Analysis of the Structure and Function of Peptide:N-Glycanase 1 and Relationship with Congenital Disorder of Deglycosylation.
Miao X; Wu J; Chen H; Lu G
Nutrients; 2022 Apr; 14(9):. PubMed ID: 35565658
[TBL] [Abstract][Full Text] [Related]
17. ELISA-based highly sensitive assay system for the detection of endogenous NGLY1 activity.
Fujihira H; Sato K; Nishiuchi Y; Murase T; Matsuda Y; Yoshida Y; Kamei T; Suzuki T
Biochem Biophys Res Commun; 2024 May; 710():149826. PubMed ID: 38581946
[TBL] [Abstract][Full Text] [Related]
18. [Recent advances in glycopeptide enrichment and mass spectrometry data interpretation approaches for glycoproteomics analyses].
Liu L; Qin H; Ye M
Se Pu; 2021 Oct; 39(10):1045-1054. PubMed ID: 34505426
[TBL] [Abstract][Full Text] [Related]
19. A method for assaying peptide: N-glycanase/N-glycanase 1 activities in crude extracts using an N-glycosylated cyclopeptide.
Hirayama H; Tachida Y; Seino J; Suzuki T
Glycobiology; 2022 Mar; 32(2):110-122. PubMed ID: 34939090
[TBL] [Abstract][Full Text] [Related]
20. Mitochondrial function requires NGLY1.
Kong J; Peng M; Ostrovsky J; Kwon YJ; Oretsky O; McCormick EM; He M; Argon Y; Falk MJ
Mitochondrion; 2018 Jan; 38():6-16. PubMed ID: 28750948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
